‘Father of Cannabis Science’ Raphael Mechoulam Dead at 92

Raphael Mechoulam, the first person to synthesize THC and the “father of cannabis science,” has died. Analysis cannabis reportHe is 92 years old and his legacy will undoubtedly live on for centuries to come. The revered chemist is also called the father of cannabis research. His groundbreaking contributions to drug discovery science include the isolation and synthesis of other cannabinoids such as cannabidiol (CBD), cannabigerol (CBG) and cannabichromene (CBC).

THC, CBD, and CBG are basically common names today, but they wouldn’t have been without Dr. Mechoulam, so smoke one for him in memory. Medical Chemistry, Hebrew University, Jerusalem, Israel A professor, his research laid the groundwork for facilitating future breakthroughs, such as lighting the human body’s internal cannabinoid receptors in the 1980s and ’90s, and got the ball (or blunt force) rolling. detailed in his 1993 academic paper entitled Molecular characterization of peripheral receptors for cannabinoids.

As Dr. Mechoulam’s friends and fellow scientists do, please pay your respects today as you join your peers in spinning the pipes of peace. “Today is a very sad day for me, the scientific community, the cannabis community. Professor Raphael Mechoulam, or as we called him Raphi, was one of the greatest scientists of all time.[s] I have met him before and he has been my teacher and mentor in many ways. [deserved] Nobel Prize! His David “Dedi” Meiri, associate professor at the Technion, Israel Institute of Technology and one of his colleagues at Mechoulam, wrote in inspiring words: online statement“Thank you Rafi for all the wonderful things you have accomplished and discovered.[ed] Thank you for all the help and support you gave me. Rest in peace my dear friend,” he continues.

Born in Sofia, Bulgaria in 1930, Mechoulam and his family emigrated to Israel and began studying chemistry. His inspiration for his successful quest for THC began after judiciously observing the mechanisms of other drugs.in an interview on CNN in 2014Mechoulam pointed out: [in the] Mid 19th century. Even in the mid-20th century, the chemistry of cannabis was unknown.So it looked like [an] Interesting project. ” according to National Library of Medicine, in 1964, he succeeded. And the backstory on how Mechoulam obtained the cannabis he studied might surprise you.

While working as a chemist at the Weizmann Institute in the early 1960s, Mechoulam obtained weed from the Israeli police. His goal was to discover and isolate what makes cannabis psychoactive. Once THC and other cannabinoids such as the aforementioned CBD and CBG were identified in 1992, Discovered by Mechoulam and his team The chemical arachidonoylethanolamine (derived from Sanskrit) you know as anandamide Anandameans bliss). Anandamide is produced independently by our body’s endocannabinoid system (just like cannabis was made to use) and activates the CB1 receptors.

A very passionate and hardworking Mechoulam continued his research until his death. At the age of 88, at the 2019 cannabis conference CannMed in California, he announced another breakthrough in overall stability. Cannabidiolic acid (CBDA)is the major phytocannabinoid in fiber and seed oil hemp, which contains anti-inflammatory, anti-spasmodic, and anti-cancer properties, and that’s probably just the tip of the iceberg. It has provided a stable and consistent platform for researching new therapies across a wide range of medical needs.” Mechoulam explained at the conferenceHe also used his stage time to encourage the scientific community to invest more in cannabis research. quoting many people in the past who have benefited greatly.”Did we have to wait 30 years? No,” he said. “We could have helped thousands of children, but we couldn’t.”

Dr. Mechoulam, rest in peace. May all who are fortunate enough to have access to his research find the power of plant medicine today.